T2 Biosystems (NASDAQ:TTOO) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report issued on Thursday. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 1.3 %

Shares of NASDAQ:TTOO opened at $0.12 on Thursday. T2 Biosystems has a one year low of $0.06 and a one year high of $6.80. The company has a 50-day simple moving average of $0.14 and a 200-day simple moving average of $0.60.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.